Compare EDD & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EDD | NUS |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.9M | 220.5M |
| IPO Year | N/A | 1996 |
| Metric | EDD | NUS |
|---|---|---|
| Price | $5.24 | $4.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 305.8K | ★ 388.1K |
| Earning Date | 01-01-0001 | 11-05-2026 |
| Dividend Yield | ★ 7.52% | 5.30% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $4.96 | $4.49 |
| 52 Week High | $6.18 | $12.03 |
| Indicator | EDD | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 30.47 | 39.68 |
| Support Level | $4.96 | N/A |
| Resistance Level | $5.66 | $4.94 |
| Average True Range (ATR) | 0.14 | 0.14 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 18.57 | 4.44 |
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.